Author

Bingyuan Liu

Guangzhou Medical University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:transcription & RNA processing· 1

Frequent Co-Authors

Aochu Liu· 1 shared Enzhe Lou· 1 shared Guanjie Peng· 1 shared Haichuan Zhang· 1 shared Jiahong LuiD· 1 shared Jinbao LiuiD· 1 shared Jinghong CheniD· 1 shared Jinxin Fang· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aochu Liu

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The transcriptional regulatory circuit as a driver and therapeutic target in CML blast crisis

Liling Jiang, Enzhe Lou, Jinxin Fang, Lizhen Jiang, Guanjie Peng, Jinghong Chen, Bingyuan Liu, Jiahong Lu, Yi Meng, Haichuan Zhang, Aochu Liu, Qiong Mao, Peilong Lai, Yueyuan Zheng, Jinbao Liu, Xianping Shi

This study identifies a transcriptional circuit in CML blast crisis that drives disease progression and shows mebendazole can inhibit it, offering a potential therapeutic strategy.

bioRxiv · Nov 2, 2025 · PreprintCancer Biology